CRISTOBAL PEREZ: Open Payments
NPI 1184633968 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 19 payments from 7 companies in 2025. Trend: 2023 $163 · 2024 $467 · 2025 $1,802
Travel & lodging: $1,138Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Aesculap, Inc. | 13 | $1,388 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| Mirum Pharmaceuticals, Inc. | 1 | $106 |
| GENZYME CORPORATION | 1 | $100 |
| SpringWorks Therapeutics, Inc. | 1 | $59 |
| UCB, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: XABO, DUPIXENT, Livmarli, GOMEKLI, Fintepla, STRATA.
Industry payments across TX — which companies pay providers there.
